MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells-Reference-Cited by-同舟云学术

MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells

Published:2019-07 Issue: Volume:133 Page:88-95
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tada Makoto,Sumi Toshiyuki,Tanaka Yusuke,Hirai Sachie,Yamaguchi Miki,Miyajima Masahiro,Niki Toshiro,Takahashi Hiroki,Watanabe Atsushi,Sakuma Yuji^ORCID

Funder

Japan Society for the Promotion of ScienceJapan Society for the Promotion of Science (JSPS)

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy;Chalela;J. Thorac. Dis.,2017

3. Comprehensive molecular profiling of lung adenocarcinoma;Cancer Genome Atlas Research Network;Nature,2014

4. Ras signaling and therapies;Young;Adv. Cancer Res.,2009

5. Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study;Serizawa;Cancer,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and efficacy of binimetinib for lung cancer: a systematic review;BMC Pulmonary Medicine;2024-08-01

2. A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations;Lung Cancer;2023-09

3. Predictive biomarkers for response to trametinib in non-small cell lung cancer;Tumor Biology;2022-12-09

4. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells;Biochemical and Biophysical Research Communications;2022-11

5. MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells;Experimental Cell Research;2021-09